Related Experiment Video
Updated: Jul 27, 2025

Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
Published on: May 7, 2020
Alu-Mediated Insertions in the DMD Gene: A Difficult Puzzle to Interpret Clinically
Annalaura Torella1,2, Alberto Budillon1, Mariateresa Zanobio1
1Department of Precision Medicine, University of Campania "Luigi Vanvitelli", Via L. De Crecchio 7, 80138 Naples, Italy.
Abstract:
Disrupting variants in the DMD gene are associated with Duchenne or Becker muscular dystrophy (DMD/BMD) or with hyperCKemia, all of which present very different degrees of clinical severity. The clinical phenotypes of these disorders could not be distinguished in infancy or early childhood. Accurate phenotype prediction based on DNA variants may therefore be required in addition to invasive tests, such as muscle biopsy. Transposon insertion is one of the rarest mutation types. Depending on their position and characteristics, transposon insertions may affect the quality and/or quantity of dystrophin mRNA, leading to unpredictable alterations in gene products. Here, we report the case of a three-year-old boy showing initial skeletal muscle involvement in whom we characterized a transposon insertion (Alu sequence) in exon 15 of the DMD gene. In similar cases, the generation of a null allele is predicted, resulting in a DMD phenotype. However, mRNA analysis of muscle biopsy tissue revealed skipping of exon 15, which restored the reading frame, thus predicting a milder phenotype. This case is similar to very few others already described in the literature. This case further enriches our knowledge of the mechanisms perturbing splicing and causing exon skipping in DMD, helping to properly guide clinical diagnosis.
Insights
Rare transposon insertions in the dystrophin (DMD) gene can cause unpredictable muscular dystrophy phenotypes. This case reveals how an Alu sequence insertion led to exon skipping, predicting a milder outcome than expected for DMD.
Area of Science:
- Genetics
- Molecular Biology
- Neurology
Background:
- Disrupting variants in the dystrophin (DMD) gene cause Duchenne/Becker muscular dystrophy (DMD/BMD) or hyperCKemia.
- Clinical severity varies greatly, making early diagnosis challenging.
- Accurate phenotype prediction from DNA variants is crucial, potentially reducing the need for invasive tests like muscle biopsy.
Observation:
- A rare transposon insertion (Alu sequence) was identified in exon 15 of the DMD gene in a 3-year-old boy with skeletal muscle involvement.
- Transposon insertions can unpredictably alter dystrophin mRNA quality or quantity.
- Typically, such insertions predict a null allele and a severe DMD phenotype.
Findings:
- Analysis of muscle biopsy mRNA revealed that the Alu insertion caused exon 15 skipping.
- Exon skipping restored the reading frame, predicting a milder clinical phenotype than initially expected.
- This observation aligns with rare documented cases of similar mechanisms.
Implications:
- This case expands knowledge of splicing perturbation mechanisms in the DMD gene.
- Understanding these mechanisms aids in predicting disease severity and guiding clinical diagnosis.
- Further research into genotype-phenotype correlations in DMD/BMD is warranted.

